From Design to Clinic: Engineered Nanobiomaterials for Immune Normalization Therapy of Cancer-Reference-Cited by-全球学者库

From Design to Clinic: Engineered Nanobiomaterials for Immune Normalization Therapy of Cancer

Published:2021-05-28 Issue:30 Volume:33 Page:2008094
ISSN:0935-9648
Container-title:Advanced Materials
language:en
Short-container-title:Adv. Mater.

Author:

Saeed Madiha¹^ORCID,Chen Fangming¹,Ye Jiayi¹,Shi Yang²,Lammers Twan²,De Geest Bruno G.³,Xu Zhi Ping⁴,Yu Haijun¹^ORCID

Affiliation:

1. State Key Laboratory of Drug Research & Center of Pharmaceutics Shanghai Institute of Materia Medica Chinese Academy of Sciences 501 Haike Road Shanghai 201203 China

2. Department of Nanomedicine and Theranostics Institute for Experimental Molecular Imaging Uniklinik RWTH Aachen and Helmholtz Institute for Biomedical Engineering Faculty of Medicine RWTH Aachen University 52074 Aachen Germany

3. Department of Pharmaceutics and Cancer Research Institute Ghent (CRIG) Ghent University Ghent 9000 Belgium

4. Australian Institute for Bioengineering and Nanotechnology The University of Queensland St. Lucia Queensland 4072 Australia

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adma.202008094

Reference276 articles.

1. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy